Clinical Trials

    Showing 1 - 1 of 1 Diabetes & Insulin Disorders

    A Multicenter, Randomized, Double-blind, Sham-controlled study for Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals with Type II Diabetes

    Status: Enrolling

    Investigator: Abhishek Kansara

    Study Coordinator: Chika Awujo

    Phone: 346.356.3676

    This research study is designed to evaluate the safety and effectiveness of the ReCET™ device for improving glycemic (blood sugar) control in individuals with T2D. This study plans to enroll a minimum of 264 and a maximum of 350 participants from ... Read more >